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antigen quantification in the natural history of
chronic hepatitis B infectionTo the Editor,
In a recent issue of the Kaohsiung Journal of Medical
Sciences, we read with interest the article by Kuo et al
[1], “Changing serum levels of quantitative hepatitis B
surface antigen (HBsAg) and hepatitis B virus DNA in
hepatitis B virus surface antigen carriers: A follow-up
study of an elderly cohort”. The authors concluded that
serum hepatitis B surface antigen (HBsAg) quantification
was well correlated with hepatitis B virus (HBV) DNA in
treatment-naı¨ve HBsAg carriers, and lower levels of
HBsAg and HBV DNA might present an inactive HBV
infection. Recent studies have demonstrated that there
was a significant correlation between HBsAg level and
cccDNA before and after antiviral therapy [2,3]. Addi-
tionally, it was reported that HBsAg levels might be
useful for discriminating different chronic hepatitis B
(CHB) phases. This relationship would allow the clinician
to screen the natural history of HBV infection and predict
treatment response in CHB patients [2]. In comparing
HBsAg level with HBV DNA, the ready availability and
inexpensiveness of HBsAg quantification may encourage
its use in clinical practice in the near future. We thank
the authors for their comprehensive contribution. How-
ever, we would like to point out several concerns
regarding this study from a methodological point of
view [1].
First, it would have been more relevant if the sample
size of CHB patients was larger. Second, secretion of HBsAg
could be strongly influenced by HBV genotype, therefore,
it would have been better if the authors had discriminated
and compared the patients according to their genotypes
[3]. Third, it was demonstrated that the HBsAg levels
tended to decline in the order of advancing liver disease,Conflicts of interest: All authors declare no conflicts of interest.
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cancer, as well as from ChildePugh Class AeC [4,5]. It has
also been reported in recent studies that HBsAg titers tend
to decrease with age during long periods of immune
pressure, in which some patients may eventually lose
HBsAg; in some patients, however, liver disease can
progress over time. From this point of view, a decline in
HBsAg and HBV DNA levels may not mean an improvement
in CHB. For this reason, it would have been better if the
authors had compared HBsAg levels according to these
parameters.
We are of the opinion that the findings of Kuo et al [1]
will lead to further research regarding the association be-
tween HBsAg titers and HBV DNA levels. It is important that
HBsAg titers be considered along with other independent
variables (e.g., age, liver fibrosis, cirrhosis) to provide the
required information.
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